Refine by
Bowel Articles & Analysis: Older
106 news found
The potential side effects of these treatments are mostly around quality of life (erectile function, urinary incontinence, bowel discomfort). Focal treatment is where doctors target only the cancer that requires intervention and can be the bridge between active surveillance and radical treatment. ...
By fostering a healthy gut environment, these strains can alleviate digestive discomfort and promote regular bowel movements. Boosted Immune System: Research suggests that certain Lactobacillus strains have the ability to modulate immune responses, contributing to a balanced immune system and reduced risk of infections. ...
” Researchers used cells from humans and mice with inammatory bowel disease, which can cause chronic pain, in order to facilitate the study. ...
Dysbiosis of intestinal flora is closely associated with the development of many diseases, such as obesity, diabetes, non-alcoholic fatty liver, inflammatory bowel disease, and tumors. “We employ state-of-the-art analytical platforms for gut microbiota metabolomics studies, including GC-MS, LC-MS, and UPLC-MS. ...
The implementation of AIR will aid in the recruitment of patients for clinical trials focused on inflammatory bowel disease (IBD). Both One GI® and Iterative Scopes are fast-growing innovators in the gastroenterology space. ...
Bioactive lipids are consistently involved in chronic inflammation for pathological characterization, such as cancer, diabetes, atherosclerosis, asthma, inflammatory bowel disease, as well as autoimmune and neurodegenerative disorders. ...
About Iterative Health Iterative Health is pioneering the use of artificial intelligence-based precision medicine in gastroenterology (GI), with the aim of helping to optimize clinical trials investigating treatment of inflammatory bowel disease (IBD) and improving the accuracy of colorectal cancer screenings. ...
This strategic partnership will lay the groundwork for future collaborations by using AIR to aid in the recruitment of patients for clinical trials in inflammatory bowel disease (IBD) and expanding Gastro Health’s clinical research capabilities. ...
About Iterative Health Iterative Health is pioneering the use of artificial intelligence-based precision medicine in gastroenterology (GI), with the aim of helping to optimize clinical trials investigating treatment of inflammatory bowel disease (IBD) and improving the accuracy of colorectal cancer screenings. ...
Lumen's clinical pipeline includes investigational biologic drugs for C. difficile infection, Covid-19, cardiometabolic disease, inflammatory bowel disease, norovirus, and traveler's diarrhea. ...
With targeted investments, we continue to make important progress in developing next-generation best-in-class candidates that reach optimal target coverage, teasing apart selectivity profiles that indicate the potential of SIK3i for rheumatological indications and SIK2/3i for inflammatory bowel disease. Our most advanced candidate, SIK3 inhibitor ‘4399, has shown strong ...
AI Recruitment (AI-R) addresses clinical trial recruitment pain points for pharmaceutical companies and clinical research teams working to surface eligible patients for inflammatory bowel disease (IBD) clinical trials. Recruiting qualified patients is one of the most significant and expensive challenges of clinical trials, but AI-R helps determine if patients are qualified for ...
About Iterative Scopes Iterative Scopes is a pioneer in the application of artificial intelligence-based precision medicine for gastroenterology with the aim of helping to optimize clinical trials investigating treatment of inflammatory bowel disease (IBD). The technology is also designed to potentially enhance colorectal cancer screenings. ...
The capital raise enables Carina to complete its Investigational New Drug (IND) enabling studies and initiate a CAR-T clinical trial of our LGR5 CAR-T cell for patients with advanced colorectal (bowel) cancer. “Colorectal cancer is Australia’s second deadliest cancer and its incidence is rising in people under the age of 50. ...
It’s an extremely versatile product with a wide range of surgical applications, from cardiac and spinal to bowel and breast, ata fraction of the cost of current lighting options” Scotland has a proud history of shaping health and patient care through research, science and innovation and is set to continue to transform the world of modern medicine. ...
C-Scan is non-invasive and requires no sedation. It requires no bowel preparation, allowing the patients to continue their daily routine with no interruption. ...
Highlights Melbourne-based contract development and manufacturing organisation Cell Therapies will manufacture Carina Biotech’s LGR5 CAR-T cells for a first-in-human clinical trial for patients with advanced colorectal (bowel) cancer. Carina’s CAR-T cells are targeted at LGR5, a cancer stem cell marker that is highly expressed on colorectal cancer and other ...
The ambition for IBP-9414 is to become the world’s first approved probiotical drug with the goal to prevent life threatening diseases in premature infants including NEC and sepsis by promoting healthy stomach-and bowel development in premature infants. IBP-9414 contains the active compound Lactobacillus reuteri, which is a human bacterial strain naturally present in breast ...
These frequencies (11-12 cpm) have previously been associated with small bowel activity. The second poster, entitled Development and Characterization of an opioid-induced constipation (OIC) model in swine: use of G-Tech wireless non-invasive patches to monitor colonic myoelectrical activity (CMA), reported on a study performed by researchers from UCLA and G-Tech. ...
” About BiomX BiomX is a clinical-stage microbiome company developing both natural and engineered phage cocktails designed to target and destroy bacteria in the treatment of chronic diseases, such as cystic fibrosis, atopic dermatitis, inflammatory bowel disease, primary sclerosing cholangitis, and colorectal cancer. ...
ByBiomX